Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
99.12
(
-0.74%
)
Bitcoin
71,025.88
(
0.36%
)
News Focus
News Focus
Post# of 257392
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122862
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: skitahoe post# 94925

Wednesday, 05/19/2010 4:47:29 PM

Wednesday, May 19, 2010 4:47:29 PM

Post# of 257392
GNVC:

The PACT Trial was a failure, but not because the drug didn't work for Pancreatic Cancer, it does.

Mark Thornton is leaving the company in three days (#msg-50340192); however, if you contact Thornton right away and inform him that TNFerade works after all, he might rescind his resignation and keep the TNFerade program going. It’s just not right for you to keep this kind of revelation to yourself. Regards, Dew


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today